P834: REAL-WORLD EVIDENCE OF SAFETY AND EFFECTIVENESS OF ECULIZUMAB AND SWITCH TO RAVULIZUMAB IN A SWISS PATIENT POPULATION WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

• A. Rovó,
• L. Simeon,
• M. Gavillet,
• K. Samii,
• N. Cantoni,
• D. Heim,
• G. Stüssi,
• M. Bissig

Affiliations

A. Rovó

1 Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, Bern

L. Simeon

2 Department of Hematology and Central Hematology Laboratory, Cantonal Hospital Lucerne, Luzern

M. Gavillet

3 Service and Central Laboratory of Hematology, Department of Oncology and Department of Laboratory Medicine and Pathology, Lausanne University Hospital (CHUV), Lausanne

K. Samii

4 Hematology Division, Department of Oncology, Geneva University Hospitals, Geneva

N. Cantoni

5 Division of Oncology, Hematology and Transfusion Medicine, Kantonsspital Aarau, Aarau

D. Heim

6 Department of Hematology, University Hospital Basel, Basel

G. Stüssi

7 Clinic of Hematology, Oncology Institute of Southern Switzerland, Bellinzona

M. Bissig

8 Department of Medical Oncology and Hematology, University Hospital of Zurich, Zurich, Switzerland